DEA Proposes Removal of Samidorphan From Controlled Substances List
The Drug Enforcement Administration is proposing to remove samidorphan from schedule II of the Controlled Substances Act, it said in a proposed rule released Dec. 9. DEA said the drug has no abuse potential. If the removal is finalized, DEA…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
would eliminate “regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle” samidorphan, it said. Comments are due Jan. 11, 2021.